CETP
| 货号 | 产品名 | CAS号 | 信息 |
|---|---|---|---|
| FB00291 | Torcetrapib | 262352-17-0 | Torcetrapib is a CETP inhibitor with IC50 of 37 nM, elevates HDL-C and reduces nonHDL-C in plasma. |
| FB11116 | Obicetrapib | 866399-87-3 | Obicetrapib is a cholesteryl ester transfer protein (CETP) inhibitor. CETP inhibitors substantially increase the concentration of high-density lipoprotein cholesterol (HDL-C), which may have a possible beneficial effect for cardiovascular disease risk reduction. |
| FB07341 | Evacetrapib | 1186486-62-3 | Evacetrapib is a potent and selective inhibitor of CETP with IC50 of 5.5 nM. |
| FB02883 | Dalcetrapib | 211513-37-0 | Dalcetrapib is a rhCETP inhibitor with IC50 of 0.2 μM. |
| FB11117 | CKD-519 | 1402796-27-3 | CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor being developed for the treatment of dyslipidemia to raise high-density lipoprotein cholesterol. |
| FB12210 | BMS 795311 | 939390-99-5 | BMS 795311 is a potent cholesteryl ester transfer protein (CETP) inhibitor with IC50 of 4 nM. |
| FB02566 | Anacetrapib | 875446-37-0 | Anacetrapib is a potent, selective, reversible rhCETP and mutant CETP (C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. |